“Rogue” DNA Rings Expose Brain Cancer’s Earliest Secrets
Scientists report that rogue rings of extrachromosomal DNA (ecDNA) can emerge strikingly early in glioblastoma and may set…
Expanding Patient Access to Comprehensive Genomic Profiling
Comprehensive genomic profiling (CGP) is reshaping cancer care by enhancing diagnostic accuracy, informing prognosis, and enabling more personalized…
What Is Cancer Cachexia? Causes, Symptoms, Diagnosis, and Treatment
IntroductionPathophysiology of cancer cachexiaClinical features and symptomsPrevalence and clinical impactDiagnosis and stagingManagement strategiesChallenges and research directionsConclusionsReferencesFurther reading Cancer…
NYU Langone strengthens world-leading GI cancer program with renowned leaders
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel…
Landmark study maps mutational landscape of triple-negative breast cancer in African American women
Triple-negative breast cancer (TNBC), the deadliest breast cancer subtype, disproportionately affects African American women – but until now,…
Dementia-Like Behavior Discovered in Pre-Cancerous Cells
Researchers have uncovered a startling link between the mechanisms of dementia and the origins of pancreatic cancer, stemming…
Doctors’ skills get worse once they’ve used AI, warns Lancet study
As healthcare becomes smarter, will doctors become dumber? The rise of AI assistants that write consultation notes or…
Neoadjuvant Immunotherapy Shows Promise in Limited-Stage SCLC
Small cell lung cancer: © Констянтин Батыльчук- stock.adobe.com Neoadjuvant immunotherapy combined with chemotherapy has demonstrated promising efficacy and…
Study Reveals Missed Opportunities for Surgical Prevention of Ovarian Cancer
Illustration of ovarian cancer: © blueringmedia – stock.adobe.com One-fourth of patients with high-grade serous carcinoma (HGSC) may have…
Pembrolizumab Hits Nearly 90% Response Rate in Desmoplastic Melanoma
Melanoma: © David A Litman – stock.adobe.com Pembrolizumab (Keytruda) elicited a clinical response in nearly 90% of patients…
Colorectal cancer rates nearly triple among younger people in Sweden
According to a study by Karolinska Institutet, nearly three times as many people under the age of 50…
New drug-releasing system eliminates tumors in 82% of high-risk bladder cancer patients
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for…